EX-21.1 4 exh2112018.htm EXHIBIT 21.1 Exhibit


Exhibit 21.1



Subsidiaries of Caladrius Biosciences, Inc.

Entity
 
Percentage of Ownership
 
Location
Amorcyte, LLC
 
100%
 
United States of America
Athelos Corporation (1)
 
97%
 
United States of America
NeoStem Oncology, LLC
 
100%
 
United States of America


(1) As of December 31, 2017, Becton Dickinson's ownership interest in Athelos Corporation was 1.6%.